These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 14748661)
1. Helicobacter pylori and molecular mechanisms of gastric carcinogenesis: targets for prevention and therapy. Juhász M; Herszényi L; Tulassay Z; Malfertheiner P; Ebert MP Expert Rev Anticancer Ther; 2004 Feb; 4(1):97-103. PubMed ID: 14748661 [TBL] [Abstract][Full Text] [Related]
2. Novel strategies in the prevention of gastric cancer. Ebert MP; Leodolter A; Malfertheiner P Hepatogastroenterology; 2001; 48(42):1569-71. PubMed ID: 11813574 [TBL] [Abstract][Full Text] [Related]
3. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. de Vries AC; Haringsma J; Kuipers EJ Helicobacter; 2007 Feb; 12(1):1-15. PubMed ID: 17241295 [TBL] [Abstract][Full Text] [Related]
4. Clinical aspects of gastric cancer and Helicobacter pylori--screening, prevention, and treatment. Selgrad M; Bornschein J; Rokkas T; Malfertheiner P Helicobacter; 2010 Sep; 15 Suppl 1():40-5. PubMed ID: 21054652 [TBL] [Abstract][Full Text] [Related]
5. Review article: Helicobacter pylori eradication for the prevention of gastric cancer. De Vries AC; Kuipers EJ Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():25-35. PubMed ID: 18081646 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Helicobacter pylori and prevention of gastric cancer. Cheung TK; Wong BC J Dig Dis; 2008 Feb; 9(1):8-13. PubMed ID: 18251788 [TBL] [Abstract][Full Text] [Related]
7. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori. Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906 [TBL] [Abstract][Full Text] [Related]
8. Genetic pathways of two types of gastric cancer. Tahara E IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305 [TBL] [Abstract][Full Text] [Related]
9. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model. Nam KT; Hahm KB; Oh SY; Yeo M; Han SU; Ahn B; Kim YB; Kang JS; Jang DD; Yang KH; Kim DY Clin Cancer Res; 2004 Dec; 10(23):8105-13. PubMed ID: 15585646 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disease: Helicobacter pylori-related gastric carcinogenesis--implications for chemoprevention. Romano M; Ricci V; Zarrilli R Nat Clin Pract Gastroenterol Hepatol; 2006 Nov; 3(11):622-32. PubMed ID: 17068500 [TBL] [Abstract][Full Text] [Related]
12. Expression of somatostatin receptor subtype 3 in the gastric mucosa of dyspeptic patients in relation to Helicobacter pylori infection and a family history of gastric cancer. Stec-Michalska K; Peczek L; Krakowiak A; Michalski B; Chojnacki J; Knopik-Dabrowicz A; Klupinska G; Nawrot B J Gastroenterol Hepatol; 2008 Mar; 23(3):424-9. PubMed ID: 17683502 [TBL] [Abstract][Full Text] [Related]